Sharon Tetlow - 07 Jun 2022 Form 4 Insider Report for DICE Therapeutics, Inc.

Role
Director
Signature
/s/ Scott Robertson as attorney-in-fact for Sharon Tetlow
Issuer symbol
N/A
Transactions as of
07 Jun 2022
Net transactions value
$0
Form type
4
Filing time
08 Jun 2022, 17:06:10 UTC
Previous filing
14 Sep 2021
Next filing
02 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DICE Stock Option (right to buy Common Stock) Award $0 +21,250 $0.000000 21,250 07 Jun 2022 Common Stock 21,250 $14.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier to occur of: (i) the one-year anniversary of the grant date and (ii) the subsequent annual meeting of the Registrant's stockholders, in each case, subject to the Reporting Holder's continued service to the Registrant.